Landmark genetics partnership to probe causes of cancer and dementia

image_pdfimage_print

Oxford Nanopore’s breakthrough genetic sequencing tech to analyse 50,000 samples from UK Biobank, to create a world-first ‘epigenetic map’.

Leave a Reply

Your email address will not be published.